ES2152324T3 - Vesiculas lipidicas multilaminares bifasicas. - Google Patents

Vesiculas lipidicas multilaminares bifasicas.

Info

Publication number
ES2152324T3
ES2152324T3 ES94922214T ES94922214T ES2152324T3 ES 2152324 T3 ES2152324 T3 ES 2152324T3 ES 94922214 T ES94922214 T ES 94922214T ES 94922214 T ES94922214 T ES 94922214T ES 2152324 T3 ES2152324 T3 ES 2152324T3
Authority
ES
Spain
Prior art keywords
lipid
multilaminary
bipassic
lipid vesicles
vesicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922214T
Other languages
English (en)
Inventor
Marianna Foldvari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaderm Laboratories Ltd
Original Assignee
Pharmaderm Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaderm Laboratories Ltd filed Critical Pharmaderm Laboratories Ltd
Application granted granted Critical
Publication of ES2152324T3 publication Critical patent/ES2152324T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

UNA VESICULA LIPIDA MULTILAMELAR BIFASICA QUE CONSTA DE UNA PLURALIDAD DE BICAPAS LIPIDAS ESPACIADAS ENTRE SI QUE INCLUYEN UN COMPONENTE FORMADOR DE LIPOSOMAS Y OPCIONALMENTE UN AGENTE BIOLOGICAMENTE ACTIVO ATRAPADO ENTRE LAS BICAPAS LIPIDAS. LA VESICULA LIPIDA TAMBIEN CONTIENE COMPARTIMIENTOS PERIFERICOS CON UNA SOLUCION ACUOSA FORMADOS ENTRE LAS BICAPAS LIPIDAS, Y UN COMPARTIMIENTO DE NUCLEO LIPOFILICO CENTRAL SUSTANCIALMENTE EN EL CENTRO DE LA VESICULA LIPIDA MULTILAMELAR.
ES94922214T 1993-07-28 1994-07-28 Vesiculas lipidicas multilaminares bifasicas. Expired - Lifetime ES2152324T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9810293A 1993-07-28 1993-07-28

Publications (1)

Publication Number Publication Date
ES2152324T3 true ES2152324T3 (es) 2001-02-01

Family

ID=22267097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922214T Expired - Lifetime ES2152324T3 (es) 1993-07-28 1994-07-28 Vesiculas lipidicas multilaminares bifasicas.

Country Status (10)

Country Link
EP (1) EP0711148B1 (es)
AT (1) ATE195866T1 (es)
AU (1) AU7343894A (es)
CA (1) CA2168260C (es)
DE (1) DE69425750T2 (es)
DK (1) DK0711148T3 (es)
ES (1) ES2152324T3 (es)
GR (1) GR3034777T3 (es)
PT (1) PT711148E (es)
WO (1) WO1995003787A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0722323T3 (da) * 1994-08-05 2000-04-03 Inpharma Sa Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotens
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
US20050175683A1 (en) * 2003-10-24 2005-08-11 Yuanpeng Zhang Preparation of lipid particles
EP2034961A1 (de) * 2006-06-30 2009-03-18 Gertrud Langhoff Solubilisatformulierungen
EP2134353B1 (en) * 2007-03-30 2016-11-16 Helix Biopharma Corp. Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
FR2939313B1 (fr) * 2008-12-10 2012-03-23 St Hubert Procede de preparation de vesicules a caractere hydrophobe comprenant une cavite interne hydrophobe.
WO2010083337A2 (en) * 2009-01-15 2010-07-22 The Regents Of The University Of Califorinia Composite nanostructures and methods for making and using them
GB201202333D0 (en) * 2012-02-10 2012-03-28 Stepan Co Structured surfactant suspending systems
US9668474B2 (en) 2012-02-10 2017-06-06 Stepan Company Structured surfactant suspending systems
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US10159646B2 (en) * 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
SG11201704885WA (en) * 2014-12-30 2017-07-28 Celltrion Inc Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
MX2019002999A (es) 2016-09-15 2019-07-18 Camurus Ab Formulaciones de analogo de prostaciclina.
EP3630067A4 (en) * 2017-05-26 2021-08-11 Altum Pharmaceuticals Inc. BIPHASIC CANNABINOID ADMINISTRATION
US20220096337A1 (en) * 2019-01-30 2022-03-31 Basf Se Cosmetic composition of liquid crystal lipid particles for personal care applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
JPH04501123A (ja) * 1989-08-01 1992-02-27 ザ　ユニヴァーシティ　オブ　ミシガン 脱水／水補給リポソームに被嚢されたペプチド／タンパク質の局所送達
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence

Also Published As

Publication number Publication date
CA2168260C (en) 2000-04-11
CA2168260A1 (en) 1995-02-09
WO1995003787A1 (en) 1995-02-09
PT711148E (pt) 2001-02-28
DE69425750T2 (de) 2001-04-26
AU7343894A (en) 1995-02-28
DE69425750D1 (de) 2000-10-05
GR3034777T3 (en) 2001-02-28
ATE195866T1 (de) 2000-09-15
EP0711148A1 (en) 1996-05-15
EP0711148B1 (en) 2000-08-30
DK0711148T3 (da) 2001-01-02

Similar Documents

Publication Publication Date Title
ES2152324T3 (es) Vesiculas lipidicas multilaminares bifasicas.
ES8603264A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco
DK433484D0 (da) Medikamentholdigt lipidvesikelpraeparat
DE69530368T2 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
AU6319698A (en) Liposomes containing active agents
ES2123284T3 (es) Un sistema de suministro liposomico para agentes biologicamente activos.
BR9508913A (pt) Preparação de lipossomas multivesiculares para liberação controlada de agentes ativos
DK1017365T3 (da) Liposomomsluttet polynukleotidsammensætning og fremgangsmåde
HK1010696A1 (en) Cosmetic delivery system for salicyclic acid and process for preparation of same
NZ503568A (en) Biphasic lipid vesicle composition for transdermal administration of an immunogen
PL334940A1 (en) Lipoid complexes and liposomes of highly insoluble platinum complexes
ES2134846T3 (es) Formulacion de antibiotico y uso para infecciones resistentes a farmacos.
HU9601476D0 (en) Process for echancing the stability of liposomal suspensions containing hydrophilic active agents
ES2185418T3 (es) Agentes previstos para tratar tumores, basados en liposomas y que contienen tamoxifeno.
GB2303791B (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
ATE199315T1 (de) Liposomzubereitungen enthaltend hybrid-interferon
SI0711148T1 (en) Biphasic multilamellar lipid vesicles
WO1997004811A3 (de) Verwendung von liposomalen zubereitungen in der indirekten mrt-lymphographie
FI970935A0 (fi) Terapeutiskt anvaendbara eterlipider och foerfaranden foer deras framstaellning
ES8600055A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711148

Country of ref document: ES